Septins guide noncentrosomal microtubules to promote focal adhesion disassembly in migrating cells.

Endothelial cell migration is critical for vascular angiogenesis and is compromised to facilitate tumor metastasis. The migratory process requires the coordinated assembly and disassembly of focal adhesions (FA), actin, and microtubules (MT). MT dynamics at FAs deliver vesicular cargoes and enhance actomyosin contractility to promote FA turnover and facilitate cell advance. Noncentrosomal (NC) MTs regulate FA dynamics and are sufficient to drive cell polarity, but how NC MTs target FAs to control FA turnover is not understood. Here, we show that Rac1 induces the assembly of FA-proximal septin filaments that promote NC MT growth into FAs and inhibit mitotic centromere-associated kinesin (MCAK)-associated MT disassembly, thereby maintaining intact MT plus ends proximal to FAs. Septin-associated MT rescue is coupled with accumulation of Aurora-A kinase and cytoplasmic linker-associated protein (CLASP) localization to the MT between septin and FAs. In this way, NC MTs are strategically positioned to undergo MCAK- and CLASP-regulated bouts of assembly and disassembly into FAs, thereby regulating FA turnover and cell migration.

Lower molecular weight fractions of PolyDADMAC coagulants disproportionately contribute to N-nitrosodimethylamine formation during water treatment.

N-nitrosodimethylamine (NDMA) is a chloramine disinfection by-product, and its formation in drinking waters can increase due to the addition of cationic polydiallyldimethylammonium chloride (polyDADMAC). PolyDADMAC is a cationic polymer added as a coagulant or coagulant aid to enhance turbidity removal during sedimentation and filtration. This paper answers two central questions to understanding the nature of the NDMA precursors in polyDADMAC. First, what is the reactivity of different molecular weight (MW) fractions of polyDADMAC with chloramines? NDMA formation potential (NDMAFP) and kinetic experiments with chloramines were conducted for non-fractionated (raw) and size-excluded fractions (<3K, 3-10K, and >10K Da.) of polyDADMAC. The lower MW fraction (<3K Da.) of polyDADMAC solutions was responsible for forming 64 ±â€¯6% of the NDMA, despite containing only 8.7 and 9.8% of the carbon or nitrogen present in the bulk polymer. The chloramine demand kinetics of the lowest MW fraction were also >2× faster than the higher MW fractions. Therefore, in a water treatment application the lower MW polyDADMAC likely contributes to most of the NDMA attributed to the use of polyDADMAC. The second question was: can 1H and 13C nuclear magnetic resonance spectroscopy (NMR) be used to characterize the molecular structures in polyDADMAC that react with chloramines? A peak for 1H NMR dimethylamine (DMA), a known low MW NDMA precursor, was found in a commercial polyDADMAC solution and decreased upon chloramination. The estimated DMA alone could not account for the observed NDMAFP, indicating the presence of other low MW precursors. Diffusion order spectroscopy (DOSY) NMR also showed multiple lower MW organics in polyDADMAC that change upon chloramination, including a 1.5× decrease in MW, suggesting chloramines cleave CC or CN bonds. These reactions may produce intermediates responsible for NDMA formation. Polymer manufacturers could use NMR to synthesize polyDADMAC with less DMA and other low MW compounds that produce NDMA upon chloramination.

The probability of seizures during EEG monitoring in critically ill adults.

OBJECTIVE: To characterize the risk for seizures over time in relation to EEG findings in hospitalized adults undergoing continuous EEG monitoring (cEEG). METHODS: Retrospective analysis of cEEG data and medical records from 625 consecutive adult inpatients monitored at a tertiary medical center. Using survival analysis methods, we estimated the time-dependent probability that a seizure will occur within the next 72-h, if no seizure has occurred yet, as a function of EEG abnormalities detected so far. RESULTS: Seizures occurred in 27% (168/625). The first seizure occurred early (<30min of monitoring) in 58% (98/168). In 527 patients without early seizures, 159 (30%) had early epileptiform abnormalities, versus 368 (70%) without. Seizures were eventually detected in 25% of patients with early epileptiform discharges, versus 8% without early discharges. The 72-h risk of seizures declined below 5% if no epileptiform abnormalities were present in the first two hours, whereas 16h of monitoring were required when epileptiform discharges were present. 20% (74/388) of patients without early epileptiform abnormalities later developed them; 23% (17/74) of these ultimately had seizures. Only 4% (12/294) experienced a seizure without preceding epileptiform abnormalities. CONCLUSIONS: Seizure risk in acute neurological illness decays rapidly, at a rate dependent on abnormalities detected early during monitoring. This study demonstrates that substantial risk stratification is possible based on early EEG abnormalities. SIGNIFICANCE: These findings have implications for patient-specific determination of the required duration of cEEG monitoring in hospitalized patients.